Cost-utility and budget impact analyses of valganciclovir for cytomegalovirus retinitis in patients with human immunodeficiency virus in Thailand
Oral valganciclovir was cost-effective and demonstrated budget reduction compared with IV ganciclovir. These findings provide valuable insights into enhancing CMVR management and ensuring efficient healthcare resource allocation.
Authors
- Nattanichcha Kulthanachairojana (ORCID: https://orcid.org/0000-0002-1590-5182)
- Jatapat Hemapanpairoa
- Tippawan Wongwian
Institutions
- Burapha University (TH)
- Thai Red Cross Society (TH)
- Queen Saovabha Memorial Institute (TH)
- Memorial Hospital (US)
- Silpakorn University (TH)
Publication Details
- Journal
- Journal of Pharmaceutical Policy and Practice
- Published
- 2025-07-21
- DOI
- https://doi.org/10.1080/20523211.2025.2529472
- Citations
- 1
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 1.35